Accordingly, treatment with a selective small molecule DCLK1 kinase inhibitor (DCLK1-IN-1) inhibits DCLK1-dependent cell growth, migration and stemness in cancer cells [46,47,48,49,50]. The gene discussed is DCLK1; the disease is cancer.